This week Dr. Erickson discussed our announcement of new work showing that about 1 in 4 people on the autism spectrum exhibit brain electrical patterns that we typically see in males with fragile X. Dr. Erickson discusses how this information is being used to design a clinical trial that will enroll both adult men with fragile X and people with autism who do not have fragile X.

Spinogenix Announces Phase 2b Trial for Autism Using Novel Brain-Wave Screening to Target Treatment